Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1987 1
1989 1
1991 3
1993 1
1995 1
1997 2
1999 3
2000 3
2002 1
2003 1
2004 2
2005 1
2010 1
2014 2
2017 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
The accuracy of computed tomography in the pretreatment staging of colorectal cancer.
Tan YN, Li XF, Li JJ, Song YM, Jiang B, Yang J, Yuan Y. Tan YN, et al. Hepatogastroenterology. 2014 Jul-Aug;61(133):1207-12. Hepatogastroenterology. 2014. PMID: 25436284 Review.
And positron emission tomography (PET) or PET/CT is recommended as a complement of CT, only for cases suspected of residual or recurrent colorectal carcinoma or before metastasectomy, not for routine use....
And positron emission tomography (PET) or PET/CT is recommended as a complement of CT, only for cases suspected of residual or recurrent
Whole-body FDG-PET imaging in the management of patients with cancer.
Hustinx R, Bénard F, Alavi A. Hustinx R, et al. Semin Nucl Med. 2002 Jan;32(1):35-46. doi: 10.1053/snuc.2002.29272. Semin Nucl Med. 2002. PMID: 11839068 Review.
Convincing data also exist to support the use of PET for evaluating patients with recurrent colorectal carcinoma, for staging and restaging lymphomas, and for diagnosing recurrent thyroid carcinoma in the presence of elevated thyroglobulin and negative 131I s …
Convincing data also exist to support the use of PET for evaluating patients with recurrent colorectal carcinoma, for s …
Prospective study on diagnostic and prognostic significance of postoperative FDG PET/CT in recurrent colorectal carcinoma patients: comparison with MRI and tumor markers.
Odalovic S, Stojiljkovic M, Sobic-Saranovic D, Pandurevic S, Brajkovic L, Milosevic I, Grozdic-Milojevic I, Artiko V. Odalovic S, et al. Neoplasma. 2017;64(6):954-961. doi: 10.4149/neo_2017_613. Neoplasma. 2017. PMID: 28895416
Management plan before the 18F-FDG PET/CT scan was considered and compared to the final treatment decision. The sensitivity, specificity, positive and negative predictive value and accuracy of 18F-FDG PET/CT and MRI in detection of recurrent colorectal cancer in patient-ba …
Management plan before the 18F-FDG PET/CT scan was considered and compared to the final treatment decision. The sensitivity, specificity, po …
Intraoperative electron beam radiotherapy in recurrent colorectal carcinoma.
Nag S, Martinez-Monge R, Martin EW. Nag S, et al. J Surg Oncol. 1999 Oct;72(2):66-71. doi: 10.1002/(sici)1096-9098(199910)72:2<66::aid-jso5>3.0.co;2-e. J Surg Oncol. 1999. PMID: 10518101
METHODS: From March 1992 to February 1996, 28 patients with recurrent colorectal carcinoma were treated with maximal surgical resection and IOERT to the pelvis (n = 20) or paraortics (n = 8). ...CONCLUSIONS: Our initial experience showed that it was feasible …
METHODS: From March 1992 to February 1996, 28 patients with recurrent colorectal carcinoma were treated with maximal su …
The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases.
Wiering B, Krabbe PF, Jager GJ, Oyen WJ, Ruers TJ. Wiering B, et al. Cancer. 2005 Dec 15;104(12):2658-70. doi: 10.1002/cncr.21569. Cancer. 2005. PMID: 16315241 Free article. Review.
Fluor-18-deoxyglucose-positron emission tomography (FDG-PET) has emerged as a promising diagnostic modality in recurrent colorectal carcinoma. Whole-body FDG-PET may be an accurate diagnostic modality to determine whether patients with recurrent hepatic disea …
Fluor-18-deoxyglucose-positron emission tomography (FDG-PET) has emerged as a promising diagnostic modality in recurrent colorecta
Evaluation of chemoradiotherapy with carbon ions and the influence of p53 mutational status in the colorectal carcinoma cell line HCT 116.
Adeberg S, Baris D, Habermehl D, Rieken S, Brons S, Weber KJ, Roth W, Debus J, Combs SE. Adeberg S, et al. Tumori. 2014 Nov-Dec;100(6):675-84. doi: 10.1700/1778.19278. Tumori. 2014. PMID: 25688502
AIMS AND BACKGROUND: Heavy ion therapy has shown promising results in the treatment of recurrent colorectal carcinoma. The present study evaluates the effect of five different cytostatic agents in combination with radiotherapy with carbon (C12) ions and photo …
AIMS AND BACKGROUND: Heavy ion therapy has shown promising results in the treatment of recurrent colorectal carcinoma. …
Preoperative scintigraphy and operative probe scintimetry of colorectal carcinoma using technetium-99m-88BV59.
Moffat FL Jr, Vargas-Cuba RD, Serafini AN, Jabir AM, Sfakianakis GN, Sittler SY, Robinson DS, Crichton VZ, Subramanian R, Murray JH, et al. Moffat FL Jr, et al. J Nucl Med. 1995 May;36(5):738-45. J Nucl Med. 1995. PMID: 7738642 Free article.
METHODS: Twelve presurgical patients with biopsy- or contrast radiographic-proven colorectal cancer or recurrent colorectal carcinoma were studied. After chest roentgenography and abdominopelvic CT, 99mTc-88BV59 was administered intravenously, planar and SPEC …
METHODS: Twelve presurgical patients with biopsy- or contrast radiographic-proven colorectal cancer or recurrent colorectal
Detection of recurrent colorectal carcinoma by 18F-FDG: comparison of the clinical performances of FDG PET and FDG CDET.
Montravers F, Grahek D, Kerrou K, Younsi N, Petegnief Y, de Beco V, Colombet-Lamau C, Talbot JN. Montravers F, et al. Nucl Med Commun. 2004 Feb;25(2):105-13. doi: 10.1097/00006231-200402000-00003. Nucl Med Commun. 2004. PMID: 15154697 Clinical Trial.

On a site basis, a highly significant reduction in sensitivity was observed for lesions < or = 10 mm vs. > 10 mm with both PET and the CDET gamma camera, but no difference was observed between PET and CDET according to the size of the lesions. CONCLUSION: For

On a site basis, a highly significant reduction in sensitivity was observed for lesions < or = 10 mm vs. > 10 mm with both PET

Surgery for recurrent colorectal carcinoma--is it worthwhile?
Pollard SG, Macfarlane R, Everett WG. Pollard SG, et al. Ann R Coll Surg Engl. 1989 Sep;71(5):293-8. Ann R Coll Surg Engl. 1989. PMID: 2478070 Free PMC article.
Following resection of metastases there is the prospect of long-term survival, but it is difficult to predict those patients who will do well....
Following resection of metastases there is the prospect of long-term survival, but it is difficult to predict those patients who will …
25 results